Keto5
LONGER • LIGHTER • BRIGHTER
Beverly Hills, CA
Food & Beverage
At Keto5, we’re on a mission to improve the quality of life for everyone. Our products dramatically increase ketone levels in the bloodstream, enabling users to achieve at least 5 times the level of ketosis achieved by diet alone. Keto5 is building a nationwide and international network of medical care professionals who will sell the products to their patients and supervise their use of the products. We are a pre-market, pre-revenue company with strategic hardware partnerships in place. We will commence building our clinical network in late Q2 of 2022.
$76,552
raised
16
Investors
$50M
Valuation
$4.75
Price per Share
$498.75
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
Reg CF
Offering
Stack Owner's Bonus & Rewards!
Members get an extra 10% shares in addition to rewards below!
Rewards
Get rewarded for investing more into Keto5:
$498+
Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
Reasons to Invest
Within 5 years, even if no additional sales are achieved other than those guaranteed by Bariatrix Nutrition as per the exclusive distribution agreement for weight loss, the company will gross a minimum of $18,500,000 revenue in 2027 with a projected 60%+ gross profit. This investment is in a company dedicated to the improvement of the health of its customers.
The global ketogenic diet market size was valued at $9.57 billion in 2019. And the ketogenic diet market is set to grow by USD 1.68 billion, progressing at a CAGR of over 5.5% between 2020 and 2025.*
Nearly 1.1M physicians practice in the US of which 381,000 are in the specialties and subspecialties that treat conditions for which Keto5 products are beneficial.**
*Information from Grandview Research and Yahoo Finance (source / source)
**Information from Statista (source)
A fully customized program to meet your healthcare goals
Weight loss is not our end goal here. It’s your empowerment to live a high-quality, sustainable lifestyle with immense health benefits.
In the nearly 7 years since the formation of Keto5, founder Dr. Michael Wool, a renowned university research physician with a background in HIV antiviral drug therapy, and Stanley Ho, an engineer, brought together a small group of physicians to explore weight control using exogenous ketone supplementation.
A small clinical trial of 49 patients demonstrated weight loss averaging 10 pounds per month over eight weeks. During that time, it was noted that Keto5 patients with complicated medical diseases including diabetes, hypertension, asthma, and certain auto-immune diseases experienced additional improvement in their symptoms, laboratory measurement of inflammation, and reduction in standard of care prescription medications.
With this research, we learned that no matter your goals, Keto5 doctors will optimize your program for your personal physiology and objectives - helping you hit targets faster and more effectively.
*Our dietary ketone supplement has not been approved by the FDA nor do our products cure or treat any disease
In addition to weight loss, many patients may benefit from achieving durable increases of their ketosis levels when facing specific medical issues — such as diabetes, heart disease, autoimmune disorders, and even cancer — or to address a psychological challenge such as anxiety or depression.
We are all unique in our backgrounds and physical makeups. This type of tailored approach is the key to lasting metabolic results. We’re here to give the whole body treatment.
THE EVOLUTION OF THE HIGH CARB DIET
Ancient humanity had 90% fewer diseases than today
Our ancestors survived on fat stores (ketones) for days while hunting. And when they finally ate, it was mostly animal fat and protein. Human metabolism is still wired to work this way. Yet a carbohydrate-heavy diet has been foisted upon us for nearly 30 years, not to mention, billions in marketing by CPGs has driven average sugar consumption to 3 pounds per week (source).
Point blank: Living off of carbs and sugar now instead of fat is making us fat. So much so that 4 in 10 Americans are obese. Not just overweight, but obese. This obesity causes chronic inflammation everywhere in the body.
(source)
So while obesity-induced inflammation is busy making us sick… along comes a viral pandemic. Recent data from the CDC demonstrates that obesity increases the risk of severe illness from COVID-19. People who are overweight (but not obese) may also be at increased risk. Obese people may have triple the risk of hospitalization due to a COVID-19 infection (source).
Promoting the therapeutic power of high ketosis levels to the American public will help solve many health problems associated with obesity. That’s where we come in.
The Solution
We’re on a mission to improve quality of life for everyone
We’re seeing increasing popularity for the ketogenic diet (ancient man diet).
And with that, Keto5 will help thousands of overweight or obese people lose weight under the direction of a physician (by far the most effective of all weight loss programs) and reduce levels of inflammation and vulnerability to a host of inflammation-related diseases. It takes the ketogenic diet to the next (and more powerful level).
KETO5 is optimizing human health and longevity through 360-degree ketogenic management. We are cultivating a network of physicians that Keto5 will specially train in all aspects of ketogenic management, including metabolic function, inflammation physiology and immunology, as well as ketogenic nutrition and diet design.
Upon joining the Keto5 program, you can choose to partner with one of these highly knowledgeable and compassionate experts, or continue working with your own personal physician as part of your supervised keto care regimen.
Our flagship product, XOGENIUS, is a ketone salt supplement that produces nutritional ketosis in minutes vs. hours or days in a ketogenic diet alone.
XOGENIUS safely yields 200% - 500% higher ketone levels in 1 dose. We believe this is upwards of 6X the potency of other formulas available today (source). And Keto5 has exclusive rights to sell to a clinical network from the patent holder of the main ingredient of XO Immune and XO Genius.
XOGENIUS has helped patients achieve a median of 10 lbs. of weight loss and 81% reduced inflammation in just 30 days during proven clinical trials (source, source). Because of this efficacy, XOGENIUS even provides Nutritional Forgiveness. This means a flexible modern diet with some carbohydrates can be enjoyed while still maintaining adequate levels of ketosis.
Keto5 develops, manufactures, and will sell through a network of healthcare professionals its Keto5 products - all of which either contain exogenous ketone salts or related products to consume with the ketone salts-based products.
We'll sell Keto5 products initially through our clinical network that in turn sell to its patients. The company will also sell directly to consumers but only with the authorization of a network physician. They will be sold to health care professionals at a wholesale price that is more than double our cost of manufacturing. Our suite of exogenous salts products for mental sharpness, brain fog, esports, and other uses will be sold directly to consumers online with or without the authorization of a Keto5 clinical network healthcare provider.
The Market
Ketogenic beverages alone are a $3B and growing category
But XOGENIUS doesn’t compete in the cluttered, low-margin, “snake oil” consumer market… Instead, we leverage a physician-only distribution network — initially targeting medical weight loss.
- The U.S. primary care physicians market size was valued at $254.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 3.02% from 2021 to 2028 (source).
- The global ketogenic diet market size was valued at $9.57 billion in 2019 (source).
- The ketogenic diet market is set to grow by $1.68 billion, progressing at a CAGR of over 5.5% between 2020 and 2025 (source).
(source)
This growth is primarily in the ketogenic diet arena. However, there is increasing awareness among both health care professionals and consumers of the benefits of ketosis both from a weight loss perspective but also the many therapeutic benefits of being in a heightened state of ketosis.
The KETO5 network of healthcare professionals will prescribe custom individual tailored ketogenic subscription plans including laboratory monitoring, telemedicine remote monitoring, health coaching encouraging the best outcomes and sustained clinical benefits far beyond DIY consumer-grade, “over-the-counter” and “online” products.
Plus, Keto5’s products produce higher levels of ketosis (typically at least 5X) than those that are conventionally available in the "over the counter" marketplace, and up to 10 times higher than with a Keto diet alone.
*Images are computer generated demo versions. Product is still currently under development
The Keto5 proprietary formulations producing these optimized ketosis levels are best managed by Keto5’s experts to achieve optimized patient results. Due to ubiquitous ketogenic diets along with the advancing patient population using exogenous ketones, questions about their use logically defaults to the primary care physician. Only a minority of physicians can adequately answer patient questions and give appropriate guidance about "Targeted Ketosis".
Our Traction
Strategic hardware partnerships are in place to complete the program offering
Here’s a closer look at what we’ve been up to, and where we are headed:
- Spent 7 years doing research with actual patients
- Spent 6 years perfecting the products
- Designed all packaging
- New company logo and visual branding
- Completed website
- Hired agency to help build a clinical network
- Completed agreement to give Keto5 exclusive rights to sell products containing GoGHB, a key and indispensable ingredient in XOGENIUS and XOImmune in the clinical arena, giving us an enormous competitive advantage
- Keto5 has recently entered into a distribution agreement with Bariatrix Nutrition, a global manufacturer and distributor of food products for the weight loss industry. Between its France and North American operations, it generates annual revenues in excess of $60M. Under the terms of the agreement, Baritrix will be the exclusive distributor of Keto5 products for weight loss. Bariatrix currently operates a clinical network of weight loss centers and physicians with more than 2,000 MDs in its network. It has also created an online portal and app that is managed by its team of registered dietitians. Under the terms of the contract that has an initial 5 year term with auto-renewals, Bariatrix is obligated to purchase sufficient quantities of Keto5 products to satisfy Keto5’s minimum purchase quantity requirements for GoBHB starting in January 2023. The Bariatrix contract alone guarantees minimum revenues for Keto5 of:
| 2023 | 2024 | 2025 | 2026 | 2027 |
| $1,655,889 | $2,721,000 | $7,074,600 | $11,972,400 | $18,502,800 |
- Gross profits increase with volume but we are projecting that they will be in the 60% range as per the agreed wholesale prices with Bariatrix will be creating new flavors for XOGENIUS and XOIMMUNE as well as new products containing GoBHB including meal replacements (shakes), bars, chips, muffins, pancake mix, soups and gummies (please see risk factors in the Form C for additional information regarding projections).
- Have experienced core team consisting of a physician, engineer, and experienced entrepreneur and operator/attorney
Keto5 will help Bariatrix increase its medical network for weight loss by co-marketing with them. Dr. Wool will be meeting with many large medical weight loss centers including IdealProtein, Metabolic, Ranier, Moxy, Lindora and others to persuade them of the benefits of products containing GoBHB for weight loss.
We believe that with a clinical network of only 1,000 health care professionals, apart from Bariatrix’s existing network (out of a target range of 1,100,000 primary care and specialist physicians) could help us reach our goal of becoming a $400 Million company. The value of the clinical network alone will be extremely valuable.
*The above testimonials may not be representative of the opinions of other medical experts or experiences of other customers and is not a guarantee of future performance or success.
Why Invest
We believe Keto5 is poised to help more than 70% of America who are overweight live healthier, longer, and happier lives
Professional and consumer awareness of the powerful therapeutic benefits of high ketone levels in humans is in its infancy. Although the term “keto” has crept into the public vernacular over the past 5 years, the enormous range of benefits of ketosis is barely understood by the population at large.
We are truly at the dawn of a new age where the power of ketones is about to be unlocked and unleashed. If this thesis is proven to be correct, then, given the company’s exclusive rights in the clinical network, we believe the potential for growth is enormous.
THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.
Offering Summary
Company | : | Keto5, Inc. |
Corporate Address | : | 300 South Beverly Drive, Suite 108, Beverly Hills, CA 90212 |
Offering Minimum | : | $10,003.50 |
Offering Maximum | : | $1,069,999.25 |
Minimum Investment Amount(per investor) | : | $498.75 |
Terms
Offering Type | : | Equity |
Security Name | : | Common Class B |
Minimum Number of Shares Offered | : | 2,106 |
Maximum Number of Shares Offered | : | 225,263 |
Price per Share | : | $4.75 |
Pre-Money Valuation | : | $50,000,001.00 |
*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.
Time-based
First 30 days, receive 5% bonus shares
Amount-based
Tier 1 Perk — Invest $5,000+ and receive 3% bonus shares
Tier 2 Perk — Invest $10,000+ and receive 19% bonus shares
Tier 3 Perk — Invest $25,000+ and receive 25% bonus shares
Tier 4 Perk — Invest $50,000+ and receive 30% bonus shares
Tier 5 Perk — Invest $75,000+ and receive 35% bonus shares
Tier 6 Perk — Invest $100,000+ and receive 40% bonus shares
*All perks occur when the offering is completed.
The 10% StartEngine Owners' Bonus
Keto5, Inc will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Class B at $5.00 / share, you will receive 110 shares of Common Class B, meaning you'll own 110 shares for $500. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus in addition to the aforementioned bonus.
Irregular Use of Proceeds
The Company will not incur any irregular use of proceeds.
Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$96,320.00
USD
$69,159.00
USD
Cash And Cash Equivalents
$4,893.00
USD
$995.00
USD
Accounts Receivable
$0.00
USD
$0.00
USD
Short Term Debt
$2,310.00
USD
$0.00
USD
Long Term Debt
$0.00
USD
$0.00
USD
Revenues And Sales
$3,900.00
USD
$1,502.00
USD
Costs Of Goods Sold
$2,766.00
USD
$611.00
USD
Taxes Paid
$0.00
USD
$0.00
USD
Net Income
-$63,129.00
USD
-$59,656.00
USD
Risks
A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.
Updates
Keto5 Has a New Patent Pending
9 hours agoMany of you have been reading about the significant percentage of rebound Covid cases for patients taking a course of Paxlovid. (1) Dr. Michael Wool, CEO of Keto5 and a renowned HIV researcher believes “The answer may lie with the fact that the central nervous system (CNS), comprised of the brain and the spinal cord is wrapped in a membrane called the blood brain barrier. This membrane often prevents the penetration of many medications including large antiviral molecules such as Paxlovid into where the SARS/Covid-19 virus can find safe harbor and re-emerge and reinfecting the bloodstream and body.” (2) The role of safely enhanced and elevated levels of ketosis may adjuvantly increase the enduring effectiveness of a 5 day course of Paxlovid. To that end, Keto5 has recently filed a provisional patent with the United States Patent and Trademark Office. Keto5 intends to file a formal patent application within the next 12 months.
(1) https://abc7.com/paxlovid-rebound-covid-pill-drug-treatment-antiviral/11820144/?ex_cid=kabcspddsa
(2) CNS penetration of potential anti‐COVID‐19 drugs. Journal of Neurology (2020) 267:1880–1882 https://doi.org/10.1007/s00415-020-09866-5
Perfect Your Keto Program with Adjustable Targeted Adjuvant Ketosis (ATAK) TM
5 days agoWe’re all built differently, and no two keto programs are exactly right for everybody.
Instead, the ideal approach is to follow a tailor-made system: designed by a trained physician who can monitor your progress, and make scientifically-informed adjustments based on your individual results.
Before Keto5, this kind of highly personalized, medically-supervised keto program with expert physicians would be quite challenging to build on your own. Yet today, we’re making this essential guidance and support widely available -- ensuring everyone has the opportunity to realize the enormous health benefits of therapeutic ketosis.
Keto5’s Adjustable Targeted Adjuvant Ketosis (ATAK) TM works naturally with your body’s built-in physiology, and dynamically optimizes your program over time to always keep you at your ideal ketogenic levels. This enables patients to not only shed pounds and maintain their target weight, but to significantly reduce the harmful inflammation that leads to so many serious diseases.
The Keto5 physician network -- already at 2,500 doctors and quickly growing -- offers highly trained and compassionate medical professionals who care deeply about your health, and who understand the science of ketosis to dial-in your perfect targeted program.
We invite you to join us in ownership of Keto5 through StartEngine as we grow to help millions of people benefit from the natural healing power of ketosis.
COVID-19: New energy for flagging immune cells
7 days ago
When T cells (blue-white sphere) fill up with energy in the form of ketone bodies (blue), they can fight viruses more effectively. Credit: © Chantal Wientjens, AG Prof. Wilhelm / University of Bonn
In severe COVID-19 patients, metabolism produces insufficient amounts of certain energy- rich compounds called ketone bodies. However, these energy carriers are needed by two important cell types in the immune system in order to fight the virus effectively. This finding could explain why some people fall ill so much more severely than others. A study led by the University of Bonn (Germany) at least points in this direction. The results have now been published in the journal Nature. They also give hope for new therapies.
Appetite often declines during illness. This also has an effect on metabolism: Since it is no longer as well supplied with carbohydrates, it switches to burning fat. This creates energy-rich molecules called ketone bodies, which may help the body to cope better with viruses.At least that is what the results of the current study suggest. "We found that patients with influenza infections produce ketone bodies in considerable quantities," explains Prof. Dr. Christoph Wilhelm from the Institute of Clinical Chemistry and Clinical
Pharmacology at the University Hospital Bonn, who is also a member of the Immunosensation2 Cluster of Excellence at the University of Bonn. "In contrast, we saw hardly any increase in COVID-19 patients, at least in those with a moderate or severe course."
In addition, it was striking that those infected with the coronavirus had lower levels of inflammatory messengers in their blood. This was particularly true for interferon-gamma. This is a cytokine secreted by a specific group of immune cells, the T- helper cells. These cells use it to summon the help of phagocytes and other defense troops of the immune system to fight viruses. For efficient production of IFN-gamma, however, the helper T cells apparently require an adequate supply of ketone bodies. If this is lacking, they produce less interferon-gamma. In addition, the helper T cells then die earlier.
Ketone bodies make immune system more powerful
The researchers also saw similar effects in another important group of immune cells, the killer T cells. "They, too, need ketone bodies to function well and effectively eliminate the virus," says Dr. Christian Bode, lecturer at the Department of Anesthesiology and Surgical Intensive Care Medicine at the University Hospital Bonn. Apparently, the ketone bodies promote the function of mitochondria, metabolic power houses fueling the immune cells. This not only ensures improved energy production, but also provides molecules that are needed for interferon production.
"Without an adequate supply of ketone bodies, on the other hand, the killer T cells and helper T cells show signs of exhaustion," Bode explains. "In this depleted state, they can no longer perform their function adequately." However, the researchers were able to revive the immune cells by placing diseased mice on a ketogenic diet (a diet low in carbohydrates and protein) or by administering ketone bodies directly. The animals then succeeded better in eliminating the virus and also developed significantly less lung damage.
Hope for new treatment options
The results therefore also raise hope for new treatment options. "It may be possible to increase the power of the body's own defenses through a targeted change in diet," says Wilhelm. "Whether this really works must now be shown by further studies." The researchers expressly advise against self-experimentation with dietary supplements or diets—these could possibly do more harm than good.The new findings could also be relevant for other infections. In the medium term, they may even contribute to new strategies to help the body fight tumors.
More information: Fotios Karagiannis et al, Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19, Nature (2022). DOI: 10.1038/s41586-022-05128-8, www.nature.com/articles/s41586-022-05128-8
Provided by University of Bonn
APA citation: COVID-19: New energy for flagging immune cells (2022, July 28) retrieved 2 August 2022 from https://medicalxpress.com/news/2022-07-covid-energy-flagging-immune-cells.html
Keto5 Shares May Qualify As QBS Shares
14 days agoUnder Section 1202 of the Internal Revenue Code, shares of certain companies that meet the requirements are eligible for Qualified Small Business Shares treatment. For shares issued by Keto5 on Start Engine to investors who hold the share for 5 years or more, up to $10,000,000 of capital gains will be excluded from taxation at the Federal level. Please see the link below from the company's accountant.
While we believe that Keto5 stock is eligible under Section 1202, in no way is to be regarded by investors as legal advice and investors should consult a tax professional to ensure that they qualify
Bariatrix Nutrition Deal Now Active
14 days agoWe are pleased to announce that Keto5’s exclusive distribution agreement with Bariatrix Nutrition, (https://www.bariatrix.com) a $120 million global manufacturer and distributor of food products for the weight loss industry, is live as of this week. Bariatrix is now Keto5's exclusive distributor of Keto5 products in the United States for weight loss (and non-exclusive for all other categories).
Under the terms of agreement, Keto5 is guaranteed minimum purchase quantities by Bariatrix totaling $42 million through 2027. As part of this agreement, Bariatrix is also facilitating access to its clinical network of weight loss centers and physicians — with more than 2,500 participating doctors — as well as its online portal and app (Setpoint / Helthtrac) https://www.setpointhealth.com/portal/home/healthtrac/index.asp managed by a team of registered dietitians.
Bariatrix and Keto5 are further jointly working on the development of other ketogenic products, including ready-to-drink ketone beverages, gummies, protein bars, and a Keto5 “flavor pack” to add to Bariatrix’s base mix for meal replacements, soups, etc.
This is just one among several significant deals currently in place or actively being negotiated by Keto5, and a recognition by the industry of the incredible potential of our products.
We invite you to join Bariatrix and our growing list of other investors in supporting Keto5’s mission of helping to end destructive chronic inflammation through the natural healing power of ketosis.
Nutritional Forgiveness TM Makes Keto a Reality for Everyday Life
15 days agoNutritional Forgiveness TM Makes Keto a Reality for Everyday Life
While the therapeutic benefits of Keto5’s patented ketone supplements can be realized to an extent without a ketogenic diet (low carb / low sugar), the combination of the two is what produces truly transformative results.
Yet given the pace and demands of daily life -- from grab-and-go lunches to quick-and-easy dinner options for the family at night -- we also realize that it can be a real challenge to stay in nutritional ketosis with a modern diet.
Because of the medical-grade, tested-safe strength of Keto5’s products -- yielding 200% - 500% higer ketone levels in minutes vs. hours or days with diet alone, and in just 1 dose -- we are the first commercially-available supplement anywhere to offer Nutritional Forgiveness TM.
This means you can enjoy a modest amount of carbohydrates / sugar, as part of a sensible keto-focused diet recommended by your physician, and still achieve your target weight loss and personal health goals with Keto5.
We believe the unique flexibility provided by our Nutritional Forgiveness TM is essential to help patients maintain compliance, and further strengthens Keto5’s competitive position in the marketplace.
We invite you to join us in ownership of Keto5 through StartEngine, and take part in a revolution poised to help tens of millions of people reclaim their health and wellbeing through the natural healing power of ketosis.
Therapeutic Ketosis Delivers Benefits Far Beyond Weight Loss
18 days ago
Diabetes, cancer, autoimmune disorders, heart disease, liver and kidney disease, Alzheimer’s — chronic inflammation can be found at the root of all of them. And obesity, which affects nearly 42% of all Americans, is one of the leading causes of this destructive condition. Nutritional ketosis, which is achieved by a ketogenic diet, offers weight loss and some reduction in inflammation. Yet because diet alone produces only a modest level of
ketones in the bloodstream, it’s not enough to make a significant impact on major inflammatory-based diseases.
For this kind of result, substantially higher levels of ketones are necessary — as much as 5 to 10 times more — which is known as therapeutic ketosis. Keto5’s products, XOGenius and XOImmune, are clinically-proven to produce this next level of ketosis, which is where the body’s natural healing systems activate.
Because Keto5’s products are so effective at helping patients achieve therapeutic
ketosis, not only do they shed pounds, but inflammation is reduced to much healthier
levels. This optimal state also activates the immune system’s T-cells, which are
responsible for attacking tumors and viruses like COVID-19.
With the support and guidance of our highly trained and compassionate network of
physicians, people across the country are regaining control of their health and their
weight through Keto5.
Notice of Material Change in Offering
21 days ago[The following is an automated notice from the StartEngine team].
Hello! Recently, a change was made to the Keto5 offering. Here's an excerpt describing the specifics of the change:
Issuer is adding new perk tiers and updating bonus shares for perks.
When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.
Dr. Bob Arnot Joins Keto5’s Advisory Board
21 days agoWe are thrilled to announce that Dr. Robert Arnot, former Chief Medical Correspondent for NBC and CBS News and New York Times bestselling author, has joined the Medical Advisory Board of Keto5.
Dr. Arnot has enjoyed a lengthy and distinguished career in journalism and medicine, reporting from the frontlines of Iraq, Sudan, Kosovo, Somalia, and Rwanda, among numerous other global locales. He also serves on the boards of multiple prominent organizations, including Harvard Medical School, Save the Children, and Lifeline Iraq, and leads clinical trials and analytical chemistry for major CPG companies.
As an accomplished elite athlete in sports ranging from Nordic ski racing to Ironman, the decision to join Keto5’s board was quite personal for Dr. Arnot. As he describes of his own use of our proprietary ketone salt supplements: “I'm getting stunning recoveries which would be otherwise unattainable. I’m also seeing strain scores, back to back, against a crowd of Ivy league sports captains — and beating them, daily, weekly, and monthly… These results are beyond anything I have ever seen with a product.”
Securing a medical advisor and board member of Dr. Arnot’s experience and stature alone is an incredible accomplishment and milestone for Keto5. Yet also finding a power user and devotee of our products in one of the best-recognized and most trusted medical correspondents of our era is truly a remarkable feat.
We invite you to join Dr. Arnot not only in ownership of Keto5, but to enjoy the performance and health benefits of achieving therapeutic ketosis through the power of our premium exogenous ketone products.
Keto5 In The News
26 days agoKeto5 In the News
We’re very excited to announce that Keto5 has recently been featured across a range of major news publications and outlets, including Yahoo! Finance, MarketWatch, Morningstar, Seeking Alpha, and Benzinga, among many others. The Yahoo! Finance article can be found here.
In total, 97 million consumers have been reached to learn about Keto5’s work, and how the natural healing power of ketosis is poised to eliminate chronic inflammation afflicting more than 70% of Americans.
This is only the beginning of the journey, and many other significant and exciting articles and releases are yet to come. But we definitely wanted to share the great momentum that’s already building, and look forward to welcoming you to the Keto5 team as owners and champions of human health.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}